MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problems
Migration or Expulsion of Device (1395); Infusion or Flow Problem (2964); Insufficient Information (3190)
|
Patient Problems
Pain (1994); Therapeutic Effects, Unexpected (2099); Headache, Lumbar Puncture (2186)
|
Event Date 10/07/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8598a, serial#: (b)(4), implanted:(b)(6) 2020, product type: catheter.Other relevant device(s) are: product id: 8598a, serial/lot #: (b)(4), ubd: 04-jun-2022, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider (hcp) via a clinical study on (b)(6) 2020 regarding a patient receiving fentanyl (500mcg at 399.71808mcg/day) and bupivacaine (5mg at 3.99718mg/day) via an implanted infusion pump.It was reported that the patient experienced no pain relief with boluses.At the last visit, both the flow rate and bolus were increased.A catheter dye study was ordered and on (b)(6) 2020 the dye study failed due to catheter dislodgement.A revision was scheduled for (b)(6) 2020.The event was ongoing.The etiology indicated the event was related to the device/therapy and was not related to the implant procedure.No further complications were reported or anticipated.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the patient and a healthcare professional (hcp) via a company representative who reportedthat the patient had increased pain and a spinal headache related to the event.During the procedure it was found that the spinal catheter had dislodged distal to the anchor.The anchor was intact.The spinal segment was explanted but a portion could not be disconnected so they added a new spinal segment and daisy chained it together, so the spinal segment was now a two piece.There were no environmental, external, or patient factors that may have led or contributed to the issue.The issue was noted to be resolved, and it was indicated that the hcp had no further information to provide regarding the event.
|
|
Search Alerts/Recalls
|
|
|